Clobetasol Related Published Studies
Well-designed clinical trials related to Clobetasol (Clobetasol Topical)
Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. [2008.09]
The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. [2008.05]
Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus. [2008.03]
A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. [2008.02]
Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study. [2007.05]
Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study. [2007.01]
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis. [2007]
Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. [2006.11]
A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. [2006.10]
Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial. [2006.09]
An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis. [2006.04]
Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis. [2006.04]
Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial. [2006.02]
Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. [2006.01]
A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis. [2006]
Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. [2005.08]
Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. [2005.05]
Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis. [2005.02]
Well-designed clinical trials possibly related to Clobetasol (Clobetasol Topical)
Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. [2008.05]
Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. [2007.07]
Miconazole as adjuvant therapy for oral lichen planus: a double-blind randomized controlled trial. [2007.06]
Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers. [2007]
Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: Results of a randomized, double-blind, vehicle-controlled study. [2006.11]
Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial. [2006.10]
Regulation of cutaneous drug-metabolizing enzymes and cytoprotective gene expression by topical drugs in human skin in vivo. [2006.08]
Prediction of survival for patients with bullous pemphigoid: a prospective study. [2005.06]
Highly potent and moderately potent topical steroids are effective in treating phimosis: a prospective randomized study. [2005.04]
Other research related to Clobetasol (Clobetasol Topical)
Different treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis. [2008.10.16]
Clobetasol propionate emollient formulation foam in the treatment of corticosteroid-responsive dermatoses. [2008.08]
Clobetasol propionate--where, when, why? [2008.07]
Clobetasol propionate emulsion formulation foam 0.05%: Review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. [2008.06.06]
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. [2008.06]
The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study. [2008.02.12]
In vivo determination of the skin atrophy potential of the super-high-potency topical corticosteroid fluocinonide 0.1% cream compared with clobetasol propionate 0.05% cream and foam, and a vehicle. [2008.01]
Bioequivalence assessment of topical clobetasol propionate products using visual and chromametric assessment of skin blanching. [2008]
Effectiveness of clobetasol propionate spray 0.05% added to other stable treatments: add-on therapy in the COBRA trial. [2007.11]
Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial. [2007.11]
Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus. [2007.03]
Evaluation of the effects of topical clobetasol propionate by visual score, electrical impedance and laser Doppler flowmetry. [2007.02]
Topical testosterone versus clobetasol for vulvar lichen sclerosus. [2007.02]
Testosterone versus clobetasol for maintenance of vulvar lichen sclerosus associated with variable degrees of squamous cell hyperplasia. [2007]
Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis. [2006.11]
Clobetasol propionate for psoriasis: are ointments really more potent? [2006.06]
Comparison of the effects of pulsed dye laser, pulsed dye laser + salicylic acid, and clobetasole propionate + salicylic acid on psoriatic plaques. [2006.01]
Effects of calcipotriol cream and ointment, clobetasol cream and ointment and tretinoin cream on the erythemogenicity of UVB. [2005.11]
Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases. [2005.09]
Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. [2005.09]
Clobetasol propionate foam in the treatment of psoriasis. [2005.08]
An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. [2005.06]
Clobetasol propionate solid lipid nanoparticles cream for effective treatment of eczema: formulation and clinical implications. [2005.03]
Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo. [2005.03]
Selective persistence of dermal CD8+ T cells in lesional plaque psoriasis after clobetasol-17 propionate treatment. [2005]
Other possibly related research studies
Assessment of Topical Corticosteroid Activity Using the Vasoconstriction Assay in Healthy Volunteers. [2006.12.21]
[Localized scleroderma (morphea)] [2006.12]
Penetration studies of topically applied substances: Optical determination of the amount of stratum corneum removed by tape stripping. [2006.09]
CD30+, large T-cell lymphoma: diagnostic distinction and management. [2006.10.31]
Skin lightening and its complications among African people living in Paris. [2006.11]
Wells syndrome: an enigmatic and therapeutically challenging disease. [2006.10]
Measurement of oedema in irritant-exposed skin by a dielectric technique. [2006.11]
Oral antifungal-exacerbated inflammatory flare-up reactions of dermatomycosis : case reports and review of the literature. [2006]
Treatment of lichen sclerosus with antibiotics. [2006.09]
Microdermabrasion as a novel tool to enhance drug delivery via the skin: an animal study. [2006.08]
Fluconazole and its place in the treatment of seborrheic dermatitis--new therapeutic possibilities. [2006]
Porokeratosis of Mibelli induced by topical corticosteroid. [2006.07]
[Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroid-induced iatrogenesis] [2006.04]
Genital lichen sclerosus in a case of male-to-female gender reassignment. [2006.09]
[Improvement of Darier's disease on treatment with topical 5-fluorouracil] [2006.04]
Psoriasis treatment in the United States at the end of the 20th century. [2006.04]
Photolocalized purpura during ciprofloxacin therapy. [2006.04]
Combination topical therapy for the treatment of psoriasis. [2006.03]
Preparation and characteristics of monostearin nanostructured lipid carriers. [2006.05.11]
[Bullous pemphigoid: diagnostics and new therapeutic strategies] [2006.02.24]
Sebaceous hyperplasia of the vulva: case report and review of the literature. [2006.01]
[Psoriasis and mud bath therapy: clinical-experimental study] [2005.07]
Peno-gingival lichen planus. [2005.12]
Targeting XIAP for the treatment of malignancy. [2006.02]
Childhood cicatricial pemphigoid confined to the vulva. [2006.01]
Cheilitis glandularis in an African-American woman: response to antibiotic therapy. [2005.11]
Lichen sclerosus involving the vagina. [2005.11]
Cutaneous glucocorticoid receptor sensitivity and pro-inflammatory cytokine levels in antidepressant-resistant depression. [2006.01]
Topical halobetasol propionate in the treatment of plaque psoriasis: a review. [2005]
Diarrhoea and rash in a retired farmer. [2005.10]
[Bullous pemphigoid] [2005.06.15]
Fatal disseminated cytomegalovirus infection in an infant with Cushing's syndrome caused by topical steroid. [2005]
Congenital becker nevus with lichen planus. [2005.07]
The role of topical corticosteroids in bullous pemphigoid in the elderly. [2005]
Sweet syndrome (acute febrile neutrophilic dermatosis) associated with pulmonary coccidioidomycosis. [2005.07]
Clinical studies of a new vehicle formulation for topical corticosteroids in the treatment of psoriasis. [2005.07]
A novel foam vehicle for delivery of topical corticosteroids. [2005.07]
A case of isolated cutaneous pseudo-inflammatory tumour. [2005.07]
Use of nonprescription topical steroids: patients' experiences. [2005.06]
Effect of topical corticosteroid application frequency on histamine-induced wheals. [2005.05]
Acrokeratoelastoidosis. [2005.05]
Successful treatment of Zoon's vulvitis with high potency topical steroid. [2006.02]
Pyostomatitis vegetans. Report of two cases and review of the literature. [2005.04]
Congenital alopecia areata. [2005.02]
Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. [2005.02]
Treatment of severe cutaneous ulcerative lichen planus with low molecular weight heparin in a patient with hepatitis C. [2007.01]
A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. [2007.03]
Clinical review of 202 patients with vulval lichen sclerosus: A possible association with psoriasis. [2007.02]
Lichen striatus following solarium exposure. [2007.05]
|
